Emerging uses of FDA Approved Drugs – by Bruce Sylvester – Heart disease patients who use statins are significantly less likely to develop depression than their counterparts who… read more.
Troublesome dyspnoea that limits sexual activity is common among older patients with COPD, according to a new study from Denmark.
The majority of patients with chronic obstructive pulmonary disease (COPD) referred for pulmonary rehabilitation have multiple extra-pulmonary comorbidities, according to a new study from the Netherlands.
Researchers from Galway have published a study that assesses the economic cost of chronic pain in Ireland.
by Dr Alison Louise Jones (pictured) – The headline figures are that the majority of women survive a diagnosis of breast cancer: 78% of those women currently diagnosed… read more.
The difficulties that many women describe as memory problems when menopause approaches are real, according to a study published today in the journal Menopause, the journal of the… read more.
A University of Miami study shows that women with non-metastatic breast cancer who are physically active and receive stress management intervention during treatment may reduce depression and lessen… read more.
Researchers from the University of Southampton, in collaboration with psychologists from six other universities, have started a study to assess the impact of a new psychological therapy for… read more.
Brief adherence programmes improve diabetes test results and depression symptoms. Patients simultaneously treated for both Type 2 diabetes and depression showed improved medication compliance and significantly improved blood… read more.
A study led by University of Michigan pain medicine specialist Dr. Carmen R. Green shows young adults who live in poor neighborhoods have tougher time managing chronic pain.
Lower back pain due to Modic changes can be hard to treat and the currently recommended therapy of exercise and staying active often does not help alleviate the… read more.
by Bruce Sylvester – Researchers report that opioid-dependent patients treated with escitalopram achieved meaningful reductions in pain severity and pain interference during the first three months of therapy.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
